Skip to main content
Top
Published in: Endocrine 1/2017

01-01-2017 | Endocrine Genetics/Epigenetics

Certain HLA alleles are associated with stress-triggered Graves’ disease and influence its course

Authors: Roberto Vita, Daniela Lapa, Francesco Trimarchi, Giuseppe Vita, Poupak Fallahi, Alessandro Antonelli, Salvatore Benvenga

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

There are no studies on HLA analysis in patients in whom Graves’ disease (GD) hyperthyroidism has been preceded by ≥1 stressful event. The aim of the present study was to identify predisposing or protecting HLA alleles and their effects on the course of GD in this subset of patients. We performed serological HLA typing in 58 Caucasian patients with stress-related GD and in 130 matched healthy controls (HC). We also performed genomic HLA typing in 20/58 patients and in all HC. Five HLA alleles and three loci were more frequent in patients compared to HC: B8, Cw7, C*07, C*17, DR3, DR4, DRB1*04, and DQ2. In contrast, B14 was less frequent in patients than in HC. Depending on outcome after ATD withdrawal (remission, exacerbation on-ATD, relapse off-ATD), in patients, some alleles/loci were over-represented, while others were under-represented. Age, FT3, and FT4 fold increase over the upper normal limit at onset were different depending on the allele/locus carried. In GD patients with stress-triggered hyperthyroidism, HLA typing may be helpful in predicting the outcome of the disease after ATD withdrawal.
Literature
1.
go back to reference R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, V.M. Montori, S.A. Rivkees, D.S. Ross, J.A. Sosa, M.N. Stan, American Thyroid Association, American Association of Clinical Endocrinologists, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 21, 593–646 (2011). Erratum in: Thyroid. 21, 1169 (2011). Thyroid. 22:1195 (2012) R.S. Bahn, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, V.M. Montori, S.A. Rivkees, D.S. Ross, J.A. Sosa, M.N. Stan, American Thyroid Association, American Association of Clinical Endocrinologists, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 21, 593–646 (2011). Erratum in: Thyroid. 21, 1169 (2011). Thyroid. 22:1195 (2012)
3.
go back to reference J. Heward, S.C. Gough, Genetic susceptibility to the development of autoimmune disease. Clin. Sci. (Lond) 93, 479–491 (1997)CrossRef J. Heward, S.C. Gough, Genetic susceptibility to the development of autoimmune disease. Clin. Sci. (Lond) 93, 479–491 (1997)CrossRef
4.
go back to reference F. Guarneri, S. Benvenga, Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr. Opin. Endocrinol. Diabetes Obes. 14, 398–409 (2007)CrossRefPubMed F. Guarneri, S. Benvenga, Environmental factors and genetic background that interact to cause autoimmune thyroid disease. Curr. Opin. Endocrinol. Diabetes Obes. 14, 398–409 (2007)CrossRefPubMed
6.
go back to reference G. Effraimidis, W.M. Wiersinga, Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur. J. Endocrinol. 170, R241–R252 (2014)CrossRefPubMed G. Effraimidis, W.M. Wiersinga, Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur. J. Endocrinol. 170, R241–R252 (2014)CrossRefPubMed
7.
go back to reference R. Vita, D. Lapa, F. Trimarchi, S. Benvenga, Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine 48, 254–263 (2015)CrossRefPubMed R. Vita, D. Lapa, F. Trimarchi, S. Benvenga, Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine 48, 254–263 (2015)CrossRefPubMed
8.
go back to reference B. Winsa, A. Karlsson, R. Bergstrom, H.O. Adami, A. Gamstedt, R. Jansson, U. Adamson, P.A. Dahlberg, Stressful life events and Graves’ disease. Lancet 338, 1475–1479 (1991)CrossRefPubMed B. Winsa, A. Karlsson, R. Bergstrom, H.O. Adami, A. Gamstedt, R. Jansson, U. Adamson, P.A. Dahlberg, Stressful life events and Graves’ disease. Lancet 338, 1475–1479 (1991)CrossRefPubMed
9.
go back to reference N. Sonino, M.E. Girelli, M. Boscaro, F. Fallo, B. Busnardo, G.A. Fava, Life events in the pathogenesis of Graves’ disease. A controlled study. Acta Endocrinol. (Copenh) 128, 293–296 (1993) N. Sonino, M.E. Girelli, M. Boscaro, F. Fallo, B. Busnardo, G.A. Fava, Life events in the pathogenesis of Graves’ disease. A controlled study. Acta Endocrinol. (Copenh) 128, 293–296 (1993)
10.
go back to reference A.W. Kung, Life events, daily stresses and coping in patients with Graves’ disease. Clin Endocrinol. (Oxf) 42, 303–308 (1995)CrossRef A.W. Kung, Life events, daily stresses and coping in patients with Graves’ disease. Clin Endocrinol. (Oxf) 42, 303–308 (1995)CrossRef
11.
go back to reference V.R. Radosavljević, S.M. Janković, J.M. Marinković, Stressful life events in the pathogenesis of Graves’ disease. Eur. J. Endocrinol. 134, 699–701 (1996)CrossRefPubMed V.R. Radosavljević, S.M. Janković, J.M. Marinković, Stressful life events in the pathogenesis of Graves’ disease. Eur. J. Endocrinol. 134, 699–701 (1996)CrossRefPubMed
12.
go back to reference K. Yoshiuchi, H. Kumano, S. Nomura, H. Yoshimura, K. Ito, Y. Kanaji, Y. Ohashi, T. Kuboki, H. Suematsu, Stressful life events and smoking were associated with Graves’ disease in women, but not in men. Psychosom. Med. 60, 182–185 (1998)CrossRefPubMed K. Yoshiuchi, H. Kumano, S. Nomura, H. Yoshimura, K. Ito, Y. Kanaji, Y. Ohashi, T. Kuboki, H. Suematsu, Stressful life events and smoking were associated with Graves’ disease in women, but not in men. Psychosom. Med. 60, 182–185 (1998)CrossRefPubMed
13.
go back to reference R.C. Martin, Triggering role of emotional stress and childbirth. Unexpected occurrence of Graves’ disease compared to 96 cases of Hashimoto thyroiditis and 97 cases of thyroid nodules. Ann. Endocrinol. 59, 107–112 (1998) R.C. Martin, Triggering role of emotional stress and childbirth. Unexpected occurrence of Graves’ disease compared to 96 cases of Hashimoto thyroiditis and 97 cases of thyroid nodules. Ann. Endocrinol. 59, 107–112 (1998)
14.
go back to reference A. Matos-Santos, E.L. Nobre, J.G.E. Costa, P.J. Nogueira, A. Macedo, A. Galvão-Teles, J.J. De Castro, Relationship between the number and impact of stressful life events and the onset of Graves’ disease and toxic nodular goitre. Clin. Endocrinol. (Oxf) 55, 15–19 (2001)CrossRef A. Matos-Santos, E.L. Nobre, J.G.E. Costa, P.J. Nogueira, A. Macedo, A. Galvão-Teles, J.J. De Castro, Relationship between the number and impact of stressful life events and the onset of Graves’ disease and toxic nodular goitre. Clin. Endocrinol. (Oxf) 55, 15–19 (2001)CrossRef
15.
go back to reference M. Bagnasco, I. Bossert, G. Pesce, Stress and autoimmune thyroid diseases. Neuroimmunomodulation 13, 309–317 (2006)CrossRefPubMed M. Bagnasco, I. Bossert, G. Pesce, Stress and autoimmune thyroid diseases. Neuroimmunomodulation 13, 309–317 (2006)CrossRefPubMed
16.
go back to reference L. Chiovato, M. Marinò, G. Perugi, E. Fiore, L. Montanelli, P. Lapi, E. Cavaliere, M. Ciampi, A. Patronelli, G. Placidi, G.F. Placidi, G.B. Cassano, A. Pinchera, Chronic recurrent stress due to panic disorder does not precipitate Graves’ disease. J. Endocrinol. Invest. 21, 758–764 (1998)CrossRefPubMed L. Chiovato, M. Marinò, G. Perugi, E. Fiore, L. Montanelli, P. Lapi, E. Cavaliere, M. Ciampi, A. Patronelli, G. Placidi, G.F. Placidi, G.B. Cassano, A. Pinchera, Chronic recurrent stress due to panic disorder does not precipitate Graves’ disease. J. Endocrinol. Invest. 21, 758–764 (1998)CrossRefPubMed
17.
go back to reference X.G. Vos, N. Smit, E. Endert, J.F. Brosschot, J.G.P. Tijssen, W.M. Wiersinga, Age and stress as determinants of the severity of hyperthyroidism caused by Graves’ disease in newly diagnosed patients. Eur. J. Endocrinol. 160, 193–199 (2009)CrossRefPubMed X.G. Vos, N. Smit, E. Endert, J.F. Brosschot, J.G.P. Tijssen, W.M. Wiersinga, Age and stress as determinants of the severity of hyperthyroidism caused by Graves’ disease in newly diagnosed patients. Eur. J. Endocrinol. 160, 193–199 (2009)CrossRefPubMed
18.
go back to reference G. Falgarone, H.M. Heshmati, R. Cohen, G. Reach, Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves’ disease. Eur. J. Endocrinol. 168, R13–R18 (2012)CrossRefPubMed G. Falgarone, H.M. Heshmati, R. Cohen, G. Reach, Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves’ disease. Eur. J. Endocrinol. 168, R13–R18 (2012)CrossRefPubMed
19.
go back to reference T.H. Brix, L. Hegedus, Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin. Endocrinol. (Oxf) 76, 457–464 (2012)CrossRef T.H. Brix, L. Hegedus, Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin. Endocrinol. (Oxf) 76, 457–464 (2012)CrossRef
21.
go back to reference M.J. Simmonds, S.C. Gough, Genetic insights into disease mechanisms of autoimmunity. Br. Med. Bull. 71, 93–113 (2005)CrossRefPubMed M.J. Simmonds, S.C. Gough, Genetic insights into disease mechanisms of autoimmunity. Br. Med. Bull. 71, 93–113 (2005)CrossRefPubMed
22.
go back to reference K.F. Tait, S.C. Gough, The genetics of autoimmune endocrine disease. Clin. Endocrinol. (Oxf) 59, 1–11 (2003)CrossRef K.F. Tait, S.C. Gough, The genetics of autoimmune endocrine disease. Clin. Endocrinol. (Oxf) 59, 1–11 (2003)CrossRef
23.
go back to reference A.P. Weetman, L. Zhang, N. Tandon, O.M. Edwards, HLA associations with autoimmune Addison’s disease. Tissue Antigens 38, 31–33 (1991)CrossRefPubMed A.P. Weetman, L. Zhang, N. Tandon, O.M. Edwards, HLA associations with autoimmune Addison’s disease. Tissue Antigens 38, 31–33 (1991)CrossRefPubMed
24.
go back to reference R.R. Graham, W.A. Ortmann, C.D. Langefeld, D. Jawaheer, S.A. Selby, P.R. Rodine, E.C. Baechler, K.E. Rohlf, K.B. Shark, K.J. Espe, L.E. Green, R.P. Nair, P.E. Stuart, J.T. Elder, R.A. King, K.L. Moser, P.M. Gaffney, T.L. Bugawan, H.A. Erlich, S.S. Rich, P.K. Gregersen, T.W. Behrens, Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71, 543–553 (2002)CrossRefPubMedPubMedCentral R.R. Graham, W.A. Ortmann, C.D. Langefeld, D. Jawaheer, S.A. Selby, P.R. Rodine, E.C. Baechler, K.E. Rohlf, K.B. Shark, K.J. Espe, L.E. Green, R.P. Nair, P.E. Stuart, J.T. Elder, R.A. King, K.L. Moser, P.M. Gaffney, T.L. Bugawan, H.A. Erlich, S.S. Rich, P.K. Gregersen, T.W. Behrens, Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71, 543–553 (2002)CrossRefPubMedPubMedCentral
25.
26.
go back to reference M.J. Simmonds, J.M. Howson, J.M. Heward, H.J. Cordell, H. Foxall, J. Carr-Smith, S.M. Gibson, N. Walker, Y. Tomer, J.A. Franklyn, J.A. Todd, S.C. Gough, Regression mapping of association between the human leukocyte antigen region and Graves disease. Am. J. Hum. Genet. 76, 157–163 (2005)CrossRefPubMed M.J. Simmonds, J.M. Howson, J.M. Heward, H.J. Cordell, H. Foxall, J. Carr-Smith, S.M. Gibson, N. Walker, Y. Tomer, J.A. Franklyn, J.A. Todd, S.C. Gough, Regression mapping of association between the human leukocyte antigen region and Graves disease. Am. J. Hum. Genet. 76, 157–163 (2005)CrossRefPubMed
27.
go back to reference A.A. Zeitlin, J.M. Heward, P.R. Newby, J.D. Carr-Smith, J.A. Franklyn, S.C. Gough, M.J. Simmonds, Analysis of HLA class II genes in Hashimoto’s thyroiditis reveals differences compared to Graves’ disease. Genes Immun. 9, 358–363 (2008)CrossRefPubMed A.A. Zeitlin, J.M. Heward, P.R. Newby, J.D. Carr-Smith, J.A. Franklyn, S.C. Gough, M.J. Simmonds, Analysis of HLA class II genes in Hashimoto’s thyroiditis reveals differences compared to Graves’ disease. Genes Immun. 9, 358–363 (2008)CrossRefPubMed
28.
go back to reference N.R. Farid, C. Thompson, HLA and autoimmune endocrine disease 1985. Mol. Biol. Med. 3, 85–97 (1986)PubMed N.R. Farid, C. Thompson, HLA and autoimmune endocrine disease 1985. Mol. Biol. Med. 3, 85–97 (1986)PubMed
29.
go back to reference S.M. McLachlan, H.A. Aliesky, C.R. Chen, R.W. Williams, B. Rapoport, Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves’ disease. PLoS One 6, e21378 (2011)CrossRefPubMedPubMedCentral S.M. McLachlan, H.A. Aliesky, C.R. Chen, R.W. Williams, B. Rapoport, Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves’ disease. PLoS One 6, e21378 (2011)CrossRefPubMedPubMedCentral
30.
go back to reference S.M. McLachlan, H. Aliesky, B. Banuelos, J. Magana, R.W. Williams, B. Rapoport, Immunoglobulin heavy chain variable region and major histocompatibility region genes are linked to induced graves’ disease in females from two very large families of recombinant inbred mice. Endocrinology 155, 4094–4103 (2014)CrossRefPubMedPubMedCentral S.M. McLachlan, H. Aliesky, B. Banuelos, J. Magana, R.W. Williams, B. Rapoport, Immunoglobulin heavy chain variable region and major histocompatibility region genes are linked to induced graves’ disease in females from two very large families of recombinant inbred mice. Endocrinology 155, 4094–4103 (2014)CrossRefPubMedPubMedCentral
31.
go back to reference P. Laurberg, G. Wallin, L. Tallstedt, M. Abraham-Nordling, G. Lundell, O. Tørring, TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur. J. Endocrinol. 158, 69–75 (2008)CrossRefPubMed P. Laurberg, G. Wallin, L. Tallstedt, M. Abraham-Nordling, G. Lundell, O. Tørring, TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur. J. Endocrinol. 158, 69–75 (2008)CrossRefPubMed
32.
go back to reference N.R. Farid, J.M. Barnard, W.H. Marshall, The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves’ disease. Tissue Antigens 8, 181–189 (1976)CrossRefPubMed N.R. Farid, J.M. Barnard, W.H. Marshall, The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves’ disease. Tissue Antigens 8, 181–189 (1976)CrossRefPubMed
33.
go back to reference P.A. Dahlberg, G. Holmlund, F.A. Karlsson, J. Safwenberg, HLA-A, -B, -C and -DR antigens in patients with Graves’ disease and their correlation with signs and clinical course. Acta Endocrinol. (Copenh) 97, 42–47 (1981) P.A. Dahlberg, G. Holmlund, F.A. Karlsson, J. Safwenberg, HLA-A, -B, -C and -DR antigens in patients with Graves’ disease and their correlation with signs and clinical course. Acta Endocrinol. (Copenh) 97, 42–47 (1981)
34.
go back to reference V. Stenszky, L. Kozma, C. Balazs, J.C. Bear, N.R. Farid, The role of HLA antigens in the manifestation and course of Graves’ disease. Mol. Biol. Med. 3, 53–62 (1986)PubMed V. Stenszky, L. Kozma, C. Balazs, J.C. Bear, N.R. Farid, The role of HLA antigens in the manifestation and course of Graves’ disease. Mol. Biol. Med. 3, 53–62 (1986)PubMed
35.
go back to reference K. Bech, B. Lumholtz, J. Nerup, M. Thomsen, P. Platz, L.P. Ryder, A. Svejgaard, K. Siersbaek-Nielsen, J.M. Hansen, J.H. Larsen, HLA antigens in Graves’ disease. Acta Endocrinol. (Copenh) 86, 510–516 (1977) K. Bech, B. Lumholtz, J. Nerup, M. Thomsen, P. Platz, L.P. Ryder, A. Svejgaard, K. Siersbaek-Nielsen, J.M. Hansen, J.H. Larsen, HLA antigens in Graves’ disease. Acta Endocrinol. (Copenh) 86, 510–516 (1977)
36.
go back to reference D.S. Singer, E. Mozes, S. Kirshner, L.D. Kohn, Role of MHC class I molecules in autoimmune disease. Crit. Rev. Immunol. 17, 463–468 (1997)PubMed D.S. Singer, E. Mozes, S. Kirshner, L.D. Kohn, Role of MHC class I molecules in autoimmune disease. Crit. Rev. Immunol. 17, 463–468 (1997)PubMed
37.
go back to reference L.J. Albert, R.D. Inman, Molecular mimicry and autoimmunity. N. Engl. J. Med. 341, 2068–2074 (1999)CrossRefPubMed L.J. Albert, R.D. Inman, Molecular mimicry and autoimmunity. N. Engl. J. Med. 341, 2068–2074 (1999)CrossRefPubMed
38.
go back to reference J.B. Jaspan, K. Sullivan, R.F. Garry, M. Lopez, M. Wolfe, S. Clejan, C. Yan, S. Tenenbaum, D.M. Sander, B. Ahmed, M. Bryer-Ash, The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves’ disease. J. Clin. Endocrinol. Metab. 81, 2271–2279 (1996)PubMed J.B. Jaspan, K. Sullivan, R.F. Garry, M. Lopez, M. Wolfe, S. Clejan, C. Yan, S. Tenenbaum, D.M. Sander, B. Ahmed, M. Bryer-Ash, The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves’ disease. J. Clin. Endocrinol. Metab. 81, 2271–2279 (1996)PubMed
40.
go back to reference E. Gregoric, J.A. Gregoric, F. Guarneri, S. Benvenga, Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine 39, 41–47 (2011)CrossRefPubMed E. Gregoric, J.A. Gregoric, F. Guarneri, S. Benvenga, Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens. Endocrine 39, 41–47 (2011)CrossRefPubMed
41.
go back to reference F. Guarneri, D. Carlotta, G. Saraceno, F. Trimarchi, S. Benvenga, Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid 21, 1283–1284 (2011)CrossRefPubMed F. Guarneri, D. Carlotta, G. Saraceno, F. Trimarchi, S. Benvenga, Bioinformatics support the possible triggering of autoimmune thyroid diseases by Yersinia enterocolitica outer membrane proteins homologous to the human thyrotropin receptor. Thyroid 21, 1283–1284 (2011)CrossRefPubMed
42.
go back to reference A. Marangou, F. Guarneri, S. Benvenga, Graves’ disease precipitated by rickettsial infection. Endocrine 50, 828–829 (2015)CrossRefPubMed A. Marangou, F. Guarneri, S. Benvenga, Graves’ disease precipitated by rickettsial infection. Endocrine 50, 828–829 (2015)CrossRefPubMed
43.
go back to reference S. Benvenga, L. Santarpia, F. Trimarchi, F. Guarneri, Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16, 225–236 (2006)CrossRefPubMed S. Benvenga, L. Santarpia, F. Trimarchi, F. Guarneri, Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16, 225–236 (2006)CrossRefPubMed
44.
go back to reference M.J. Simmonds, J.M. Howson, J.M. Heward, J. Carr-Smith, J.A. Franklyn, J.A. Todd, S.C. Gough, A novel and major association of HLA-C in Graves’ disease that eclipses the classical HLA-DRB1 effect. Hum. Mol. Genet. 16, 2149–2153 (2007)CrossRefPubMed M.J. Simmonds, J.M. Howson, J.M. Heward, J. Carr-Smith, J.A. Franklyn, J.A. Todd, S.C. Gough, A novel and major association of HLA-C in Graves’ disease that eclipses the classical HLA-DRB1 effect. Hum. Mol. Genet. 16, 2149–2153 (2007)CrossRefPubMed
45.
go back to reference A. Huber, F. Menconi, S. Corathers, E.M. Jacobson, Y. Tomer, Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev. 29, 697–725 (2008)CrossRefPubMedPubMedCentral A. Huber, F. Menconi, S. Corathers, E.M. Jacobson, Y. Tomer, Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev. 29, 697–725 (2008)CrossRefPubMedPubMedCentral
46.
go back to reference Q.Y. Chen, W. Huang, J.X. She, F. Baxter, R. Volpe, N.K. Maclaren, HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves’ disease in North American Caucasians, whereas DRB1*07 is protective. J. Clin. Endocrinol. Metab. 84, 3182–3186 (1999)PubMed Q.Y. Chen, W. Huang, J.X. She, F. Baxter, R. Volpe, N.K. Maclaren, HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves’ disease in North American Caucasians, whereas DRB1*07 is protective. J. Clin. Endocrinol. Metab. 84, 3182–3186 (1999)PubMed
47.
go back to reference H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J. Autoimmun. 64, 82–90 (2015)CrossRefPubMedPubMedCentral H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J. Autoimmun. 64, 82–90 (2015)CrossRefPubMedPubMedCentral
48.
go back to reference A. Petrone, G. Giorgi, C.A. Mesturino, M. Capizzi, I. Cascino, L. Nistico, J. Osborn, U. Di Mario, R. Buzzetti, Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto’s thyroiditis in an Italian population. Thyroid 11, 171–175 (2001)CrossRefPubMed A. Petrone, G. Giorgi, C.A. Mesturino, M. Capizzi, I. Cascino, L. Nistico, J. Osborn, U. Di Mario, R. Buzzetti, Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto’s thyroiditis in an Italian population. Thyroid 11, 171–175 (2001)CrossRefPubMed
Metadata
Title
Certain HLA alleles are associated with stress-triggered Graves’ disease and influence its course
Authors
Roberto Vita
Daniela Lapa
Francesco Trimarchi
Giuseppe Vita
Poupak Fallahi
Alessandro Antonelli
Salvatore Benvenga
Publication date
01-01-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0909-6

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.